I felt the fragility of life for the first time and I had to look at what it meant to lose someone you love. The experience ...

A 22-month survival benefit was seen for a subset of ALS patients whose disease did not progress when treated with NP001 in ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

Over the course of the last three years, Brooke Eby has documented the progression of her condition for an audience of over ...

Dozens of people in one North Carolina family all have amyotrophic lateral sclerosis, a deadly disease with no cure that is ...

There's really no guide with ALS. If you were to look at 10 people with this disease in a line, I swear you wouldn't be able to tell whose progression is the fastest and whose is the slowest.

As state legislatures are beginning their 2025 sessions, the ALS Association has released its latest ALS State Policy Report ...

Zydus has announced that the USFDA has granted Orphan Drug Designation (ODD) to Usnoflast, a novel oral NLRP3 inhibitor, for ...

Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for ...